At Thermo Fisher Scientific, we are helping to advance haemato-oncology research by developing innovative and advanced molecular testing solutions.
Join our symposium at EA4HP to hear a panel of experts share their insights on NGS for lymphoid malignancy research and how the Ion AmpliSeq Liverpool Lymphoid Network Panel can provide fast and comprehensive results for accurate characterization.
Join our upcoming symposium
Date: Sept 23, 2024
Time: 17.15h – 18.15h CEST
Lymphoid disorders are heterogeneous and complex, making them challenging to analyze. There are a growing number of relevant biomarkers enabling a more complete and accurate characterization. Next-generation sequencing (NGS) is emerging as an important technique for simplifying lymphoid testing due to its ability to assess multiple genetic variants in a single test.
In this symposium, Dr. Campo will begin by introducing the role of NGS for lymphoid malignancies. Next, Dr. Menon will discuss the Liverpool Lymphoid Network, a community network of laboratories dedicated to advancing lymphoid molecular testing, and explain the comprehensive design of the new Ion AmpliSeq Liverpool Lymphoid Network Panel.
Lastly, Dr. Frigola will share his experience using the Liverpool Lymphoid Network Panel and provide compelling analytical data from his lab to demonstrate the value of NGS for lymphoid malignancy studies.
Dr. Elias Campo
Senior Consultant and Professor of Pathology,
Hospital Clinic Barcelona, University of Barcelona, IDIBAPS
Dr. Geetha Menon
Clinical Director,
Cheshire & Merseyside Cancer Network, Liverpool Clinical Laboratories
Dr. Gerard Frigola
Hematopathologist,
Hospital Clinic Barcelona, University of Barcelona, IDIBAPS
One of the only myeloid genomic profiling solution that can deliver an NGS report, covering key DNA and RNA targets, in as little as 24 hours on the Ion Torrent Genexus System. Learn More
Advanced NGS solutions that can sequence multiple B- and T-cell receptor targets in a single reaction for highly sensitive and specific clone detection. Learn More
Profile a range of lymphoid mutations in a single test in as little as 24 hours and access a community network of leading researchers.
Learn More
Experience our new interactive virtual demo
The Ion Torrent™ Genexus™ System is a turnkey next-generation sequencing (NGS) solution that automates the end-to-end workflow from the biological specimen all the way to the final report and delivers results in as little as 24 hours.*
Thinking about how the Genexus System works and how it could fit into your lab?
In our virtual laboratory environment powered by augmented reality (AR) technology, you can see:
Request a quote or personal demonstration from a Thermo Fisher Representative.
For Research Use Only. Not for use in diagnostic procedures.
*Processing times for individual sample types vary
Case number: 56075 (0824)
Would you like to speak with a Thermo Fisher Scientific representative?
Click the button below to request contact.
We've detected your location to be Japan.
Sorry, you cannot access this website. The content on www.oncomine.com is only intended for healthcare professionals. Formore information on our research solutions, please visit ThermoFisher.com
このウェブサイトは、日本国内の医療関係者の方への情報提供を目的としており、一般の方に対する情報提供を目的としたものではないことをご了承ください。研究用製品の情報はThermoFisher.comよりご覧ください。
